1-11 of 11
Jose A. Karam
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correction: Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer

Sophie J. Cowman, Daniel G. Fuja, Xian-De Liu, Rebecca S. Slack Tidwell, Neelima Kandula, Deepika Sirohi, Archana M. Agarwal, Lyska L. Emerson, Sheryl R. Tripp, Jeffrey S. Mohlman, Miekan Stonhill, Guillermina Garcia, Christopher J. Conley, Adam A. Olalde, Timothy Sargis, Adela Ramirez-Torres, Jose A. Karam, Christopher G. Wood, Kanishka Sircar, Pheroze Tamboli, Kenneth Boucher, Benjamin Maughan, Benjamin T. Spike, Thai H. Ho, Neeraj Agarwal, Eric Jonasch, Mei Yee Koh
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (11): 3265.
https://doi.org/10.1158/1078-0432.CCR-21-1235
Published: 01 June 2021
View article titled, Correction: Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer
Open the PDF for Correction: Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer in another window
Journal Articles

Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer

Sophie J. Cowman, Daniel G. Fuja, Xian-De Liu, Rebecca S. Slack Tidwell, Neelima Kandula, Deepika Sirohi, Archana M. Agarwal, Lyska L. Emerson, Sheryl R. Tripp, Jeffrey S. Mohlman, Miekan Stonhill, Guillermina Garcia, Christopher J. Conley, Adam A. Olalde, Timothy Sargis, Adela Ramirez-Torres, Jose A. Karam, Christopher G. Wood, Kanishka Sircar, Pheroze Tamboli, Kenneth Boucher, Benjamin Maughan, Benjamin T. Spike, Thai H. Ho, Neeraj Agarwal, Eric Jonasch, Mei Yee Koh
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (18): 4970–4982.
https://doi.org/10.1158/1078-0432.CCR-19-3890
Published: 15 September 2020
View article titled, Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer
Open the PDF for Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer in another window
Includes: Supplementary data
Journal Articles

DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas

Gabriel G. Malouf, Xiaoping Su, Jianping Zhang, Chad J. Creighton, Thai H. Ho, Yue Lu, Noël J.-M. Raynal, Jose A. Karam, Pheroze Tamboli, Frederick Allanick, Roger Mouawad, Jean-Philippe Spano, David Khayat, Christopher G. Wood, Jaroslav Jelinek, Nizar M. Tannir
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (24): 6236–6246.
https://doi.org/10.1158/1078-0432.CCR-15-1217
Published: 15 December 2016
View article titled, DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas
Open the PDF for DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas in another window
Includes: Supplementary data
Journal Articles

Genomic DNA Hypomethylation and Risk of Renal Cell Carcinoma: A Case–Control Study

Julia Mendoza- Pérez, Jian Gu, Luis A. Herrera, Nizar M. Tannir, Surena F. Matin, Jose A. Karam, Maosheng Huang, David W. Chang, Christopher G. Wood, Xifeng Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (8): 2074–2082.
https://doi.org/10.1158/1078-0432.CCR-15-0977
Published: 14 April 2016
View article titled, Genomic DNA Hypomethylation and Risk of Renal Cell Carcinoma: A Case–Control Study
Open the PDF for Genomic DNA Hypomethylation and Risk of Renal Cell Carcinoma: A Case–Control Study in another window
Includes: Supplementary data
Journal Articles

Survivin as a Prognostic Marker for Urothelial Carcinoma of the Bladder: A Multicenter External Validation Study

Shahrokh F. Shariat, Pierre I. Karakiewicz, Guilherme Godoy, Jose A. Karam, Raheela Ashfaq, Yves Fradet, Hendrik Isbarn, Francesco Montorsi, Claudio Jeldres, Patrick J. Bastian, Matthew E. Nielsen, Stefan C. Mller, Arthur I. Sagalowsky, Yair Lotan
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (22): 7012–7019.
https://doi.org/10.1158/1078-0432.CCR-08-2554
Published: 11 November 2009
View article titled, Survivin as a Prognostic Marker for Urothelial Carcinoma of the Bladder: A Multicenter External Validation Study
Open the PDF for Survivin as a Prognostic Marker for Urothelial Carcinoma of the Bladder: A Multicenter External Validation Study in another window
Journal Articles

Improved Prediction of Disease Relapse after Radical Prostatectomy through a Panel of Preoperative Blood-Based Biomarkers

Shahrokh F. Shariat, Jose A. Karam, Jochen Walz, Claus G. Roehrborn, Francesco Montorsi, Vitaly Margulis, Fred Saad, Kevin M. Slawin, Pierre I. Karakiewicz
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (12): 3785–3791.
https://doi.org/10.1158/1078-0432.CCR-07-4969
Published: 16 June 2008
View article titled, Improved Prediction of Disease Relapse after Radical Prostatectomy through a Panel of Preoperative Blood-Based Biomarkers
Open the PDF for Improved Prediction of Disease Relapse after Radical Prostatectomy through a Panel of Preoperative Blood-Based Biomarkers in another window
Journal Articles

Preoperative Plasma Endoglin Levels Predict Biochemical Progression After Radical Prostatectomy

Robert S. Svatek, Jose A. Karam, Claus G. Roehrborn, Pierre I. Karakiewicz, Kevin M. Slawin, Shahrokh F. Shariat
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (11): 3362–3366.
https://doi.org/10.1158/1078-0432.CCR-07-4707
Published: 02 June 2008
View article titled, Preoperative Plasma Endoglin Levels Predict Biochemical Progression After Radical Prostatectomy
Open the PDF for Preoperative Plasma Endoglin Levels Predict Biochemical Progression After Radical Prostatectomy in another window
Journal Articles

Use of Preoperative Plasma Endoglin for Prediction of Lymph Node Metastasis in Patients with Clinically Localized Prostate Cancer

Jose A. Karam, Robert S. Svatek, Pierre I. Karakiewicz, Andrea Gallina, Claus G. Roehrborn, Kevin M. Slawin, Shahrokh F. Shariat
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (5): 1418–1422.
https://doi.org/10.1158/1078-0432.CCR-07-0901
Published: 03 March 2008
View article titled, Use of Preoperative Plasma Endoglin for Prediction of Lymph Node Metastasis in Patients with Clinically Localized Prostate Cancer
Open the PDF for Use of Preoperative Plasma Endoglin for Prediction of Lymph Node Metastasis in Patients with Clinically Localized Prostate Cancer in another window
Journal Articles

Effect of Trans-2,3-Dimethoxycinnamoyl Azide on Enhancing Antitumor Activity of Romidepsin on Human Bladder Cancer

Jinhai Fan, Jennifer Stanfield, Yi Guo, Jose A. Karam, Eugene Frenkel, Xiankai Sun, Jer-Tsong Hsieh
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (4): 1200–1207.
https://doi.org/10.1158/1078-0432.CCR-07-1656
Published: 15 February 2008
View article titled, Effect of <em>Trans</em>-2,3-Dimethoxycinnamoyl Azide on Enhancing Antitumor Activity of Romidepsin on Human Bladder Cancer
Open the PDF for Effect of <em>Trans</em>-2,3-Dimethoxycinnamoyl Azide on Enhancing Antitumor Activity of Romidepsin on Human Bladder Cancer in another window
Includes: Supplementary data
Journal Articles

Preoperative Plasma HER2 and Epidermal Growth Factor Receptor for Staging and Prognostication in Patients with Clinically Localized Prostate Cancer

Shahrokh F. Shariat, Karim Bensalah, Jose A. Karam, Claus G. Roehrborn, Andrea Gallina, Yair Lotan, Kevin M. Slawin, Pierre I. Karakiewicz
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (18): 5377–5384.
https://doi.org/10.1158/1078-0432.CCR-07-0330
Published: 17 September 2007
View article titled, Preoperative Plasma HER2 and Epidermal Growth Factor Receptor for Staging and Prognostication in Patients with Clinically Localized Prostate Cancer
Open the PDF for Preoperative Plasma HER2 and Epidermal Growth Factor Receptor for Staging and Prognostication in Patients with Clinically Localized Prostate Cancer in another window
Journal Articles

Decreased DOC-2/DAB2 Expression in Urothelial Carcinoma of the Bladder

Jose A. Karam, Shahrokh F. Shariat, Hong-Ying Huang, Rey-Chen Pong, Raheela Ashfaq, Ellen Shapiro, Yair Lotan, Arthur I. Sagalowsky, Xue-Ru Wu, Jer-Tsong Hsieh
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (15): 4400–4406.
https://doi.org/10.1158/1078-0432.CCR-07-0287
Published: 01 August 2007
View article titled, Decreased DOC-2/DAB2 Expression in Urothelial Carcinoma of the Bladder
Open the PDF for Decreased DOC-2/DAB2 Expression in Urothelial Carcinoma of the Bladder in another window